Browsing: Pharmaceuticals
UnitedHealth Group’s Profit Forecast Cut and Its Implications for the Medicare Industry UnitedHealth Group experienced…
Eli Lilly’s Orforglipron: A Promising Step in Obesity and Diabetes Treatment Overview of the Clinical…
Pfizer Discontinues Development of Danuglipron Following Safety Concerns Pfizer Inc. announced on Monday that it…
Effects of Pharmaceutical Tariffs: A Comprehensive Analysis The pharmaceutical industry is facing challenges as President…
FDA Division Cuts Impact Health Care Training and Development In a significant move impacting public…
Walgreens Fiscal Q2 Earnings Surpass Expectations Ahead of Private Acquisition Walgreens has announced its fiscal…
CMS Implements Job Cuts Amid HHS Restructuring Under Robert F. Kennedy Jr. An aerial view…
Rybelsus: A New Hope for Diabetes Patients at Risk of Heart Disease Clinical Trial Insights…
Eli Lilly’s Upcoming Oral Obesity Pill: Key Insights and Implications A sign displaying Eli Lilly’s…
End of Compounded Versions of Mounjaro and Zepbound: What Lies Ahead? This week marked a…